• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

6分钟步行试验期间运动诱发的氧饱和度下降和心率反应对劳力性呼吸困难患者肺动脉高压的预测价值:一项回顾性队列研究

Exercise-Induced Oxygen Desaturation and Heart Rate Response During 6-Min Walk Test Predict Pulmonary Hypertension in Exertional Dyspnea: A Retrospective Cohort Study.

作者信息

Zhang Haojie, Yan Menghuan, Li Feng, Chen Qi, Lu Rui, Wang Ziyu, Zheng Xuan, Zhang Gangcheng

机构信息

Center of Structural Heart Disease Zhongnan Hospital of Wuhan University Wuhan China.

Key Laboratory of Artificial Micro-Structures of Ministry of Education, School of Physics and Technology Wuhan University Wuhan China.

出版信息

Pulm Circ. 2025 Jun 25;15(2):e70120. doi: 10.1002/pul2.70120. eCollection 2025 Apr.

DOI:10.1002/pul2.70120
PMID:40575181
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12197869/
Abstract

Pulmonary hypertension (PH) is a life-threatening condition frequently associated with exertional dyspnea. It remains diagnostically challenging due to limitations in current screening modalities. While the 6-min walk test (6MWT) has been applied for risk stratification in confirmed PH, its potential role in screening remains unexplored. This retrospective cohort study investigated the diagnostic utility of 6MWT-derived parameters in 180 patients with exertional dyspnea. PH diagnosis was confirmed by right heart catheterization with the definition of mean pulmonary artery pressure > 20 mmHg. Among 79 PH patients (43.9%), a significantly reduced 6-min walk distance (6MWD) was observed compared to non-PH patients (469.5 ± 106.4 m vs. 509.8 ± 74.9 m,  = 0.019). Continuous physiological monitoring revealed that the SpO₂ trough and the heart rate (HR) peak occurred at different time points during 6MWT. Propensity score-matched case-control analysis further demonstrated greater exercise-induced desaturation of SpO from the rest to minimal levels (ΔSpO₂ : 9 ± 9% vs. 4 ± 6%,  < 0.001) and exaggerated HR response from the rest to maximal levels (ΔHR : 51±21bpm vs. 34±14bpm,  < 0.001) in PH patients. Multivariable analysis identified ΔSpO₂  ≥ 5% (AUC = 0.715, 95% CI: 0.640-0.852;  < 0.001) and ΔHR  ≥ 42 bpm (AUC = 0.740, 95% CI: 0.656-0.823;  < 0.001) as independent predictors of PH. The number of these predictors discriminated the risk of PH in dyspneic patients. A risk-stratification model incorporating these thresholds demonstrated improved predictive value for PH screening, with a C-statistic of 0.786 (95% CI: 0.710-0.863,  < 0.001). These findings suggest that parameters derived from the 6MWT, particularly exercise-induced SpO₂ desaturation and HR response, may facilitate noninvasive PH screening in exertional dyspneic patients.

摘要

肺动脉高压(PH)是一种常与劳力性呼吸困难相关的危及生命的疾病。由于当前筛查方式存在局限性,其诊断仍具有挑战性。虽然6分钟步行试验(6MWT)已用于确诊PH患者的风险分层,但其在筛查中的潜在作用仍未得到探索。这项回顾性队列研究调查了6MWT衍生参数在180例劳力性呼吸困难患者中的诊断效用。通过右心导管检查确诊PH,定义为平均肺动脉压>20 mmHg。在79例PH患者(43.9%)中,与非PH患者相比,观察到6分钟步行距离(6MWD)显著缩短(469.5±106.4米对509.8±74.9米,P = 0.019)。连续生理监测显示,SpO₂谷值和心率(HR)峰值在6MWT期间出现在不同时间点。倾向评分匹配的病例对照分析进一步表明,PH患者从静息到最低水平的运动诱发SpO₂去饱和更大(ΔSpO₂:9±9%对4±6%,P<0.001),从静息到最高水平的HR反应更夸张(ΔHR:51±21次/分对34±14次/分,P<0.001)。多变量分析确定ΔSpO₂≥5%(AUC = 0.715,95%CI:0.640 - 0.852;P<0.001)和ΔHR≥42次/分(AUC = 0.740,95%CI:0.656 - 0.823;P<0.001)为PH的独立预测因素。这些预测因素的数量可区分呼吸困难患者的PH风险。纳入这些阈值的风险分层模型对PH筛查的预测价值有所提高,C统计量为0.786(95%CI:0.710 - 0.863,P<0.001)。这些发现表明,6MWT衍生的参数,特别是运动诱发的SpO₂去饱和和HR反应,可能有助于对劳力性呼吸困难患者进行无创PH筛查。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c551/12197869/ee58612ac34f/PUL2-15-e70120-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c551/12197869/58fb15d55453/PUL2-15-e70120-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c551/12197869/332fcdf245d6/PUL2-15-e70120-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c551/12197869/b7b8769d3685/PUL2-15-e70120-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c551/12197869/ee58612ac34f/PUL2-15-e70120-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c551/12197869/58fb15d55453/PUL2-15-e70120-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c551/12197869/332fcdf245d6/PUL2-15-e70120-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c551/12197869/b7b8769d3685/PUL2-15-e70120-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c551/12197869/ee58612ac34f/PUL2-15-e70120-g002.jpg

相似文献

1
Exercise-Induced Oxygen Desaturation and Heart Rate Response During 6-Min Walk Test Predict Pulmonary Hypertension in Exertional Dyspnea: A Retrospective Cohort Study.6分钟步行试验期间运动诱发的氧饱和度下降和心率反应对劳力性呼吸困难患者肺动脉高压的预测价值:一项回顾性队列研究
Pulm Circ. 2025 Jun 25;15(2):e70120. doi: 10.1002/pul2.70120. eCollection 2025 Apr.
2
Doppler trans-thoracic echocardiography for detection of pulmonary hypertension in adults.经胸多普勒超声心动图用于检测成人肺动脉高压。
Cochrane Database Syst Rev. 2022 May 9;5(5):CD012809. doi: 10.1002/14651858.CD012809.pub2.
3
Pulmonary rehabilitation versus usual care for adults with asthma.肺康复治疗与常规护理对哮喘成人的影响比较。
Cochrane Database Syst Rev. 2022 Aug 22;8(8):CD013485. doi: 10.1002/14651858.CD013485.pub2.
4
Inspiratory muscle training, with or without concomitant pulmonary rehabilitation, for chronic obstructive pulmonary disease (COPD).吸气肌训练,联合或不联合肺康复治疗,用于慢性阻塞性肺疾病(COPD)。
Cochrane Database Syst Rev. 2023 Jan 6;1(1):CD013778. doi: 10.1002/14651858.CD013778.pub2.
5
Pulmonary rehabilitation for interstitial lung disease.间质性肺疾病的肺康复治疗。
Cochrane Database Syst Rev. 2021 Feb 1;2(2):CD006322. doi: 10.1002/14651858.CD006322.pub4.
6
Exercise-based rehabilitation programmes for pulmonary hypertension.基于运动的肺动脉高压康复方案。
Cochrane Database Syst Rev. 2023 Mar 22;3(3):CD011285. doi: 10.1002/14651858.CD011285.pub3.
7
Non-invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic obstructive pulmonary disease.无创通气用于治疗慢性阻塞性肺疾病急性加重所致的急性高碳酸血症性呼吸衰竭。
Cochrane Database Syst Rev. 2017 Jul 13;7(7):CD004104. doi: 10.1002/14651858.CD004104.pub4.
8
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
9
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
10
Physical exercise training interventions for children and young adults during and after treatment for childhood cancer.针对儿童癌症治疗期间及治疗后的儿童和青少年的体育锻炼训练干预措施。
Cochrane Database Syst Rev. 2016 Mar 31;3(3):CD008796. doi: 10.1002/14651858.CD008796.pub3.

本文引用的文献

1
Usefulness of oxygen uptake efficiency slope in a 6 min walk test in chronic heart failure.6 分钟步行试验中摄氧量效率斜率在慢性心力衰竭中的作用。
ESC Heart Fail. 2024 Aug;11(4):2055-2062. doi: 10.1002/ehf2.14754. Epub 2024 Mar 26.
2
Using change in 6-minute walk distance to predict survival in progressive pulmonary fibrosis: A promising measure in need of precision.利用6分钟步行距离的变化预测进行性肺纤维化的生存率:一项有待精确化的有前景的指标。
Respirology. 2024 May;29(5):359-360. doi: 10.1111/resp.14696. Epub 2024 Feb 25.
3
Pulmonary hypertension.
肺动脉高压
Nat Rev Dis Primers. 2024 Jan 4;10(1):1. doi: 10.1038/s41572-023-00486-7.
4
Heart Rate Response Predicts 6-Minutes Walking Distance in Pulmonary Arterial Hypertension.心率反应可预测肺动脉高压患者的 6 分钟步行距离。
Am J Cardiol. 2023 Oct 1;204:207-214. doi: 10.1016/j.amjcard.2023.07.056. Epub 2023 Aug 7.
5
Early Desaturation During 6-Minute Walk Test is a Predictor of Mortality in COPD.6分钟步行试验期间的早期氧饱和度下降是慢性阻塞性肺疾病死亡率的一个预测指标。
Lung. 2023 Apr;201(2):217-224. doi: 10.1007/s00408-023-00613-x. Epub 2023 Apr 10.
6
Six-Minute Walking Test and 30 Seconds Chair-Stand-Test as Predictors of Mortality in COPD - A Cohort Study.六分钟步行试验和 30 秒椅立试验预测 COPD 患者死亡率的队列研究。
Int J Chron Obstruct Pulmon Dis. 2022 Oct 4;17:2461-2469. doi: 10.2147/COPD.S373272. eCollection 2022.
7
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.2022年欧洲心脏病学会/欧洲呼吸学会肺动脉高压诊断和治疗指南。
Eur Respir J. 2023 Jan 6;61(1). doi: 10.1183/13993003.00879-2022. Print 2023 Jan.
8
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.2022年欧洲心脏病学会/欧洲呼吸学会肺动脉高压诊断和治疗指南。
Eur Heart J. 2022 Oct 11;43(38):3618-3731. doi: 10.1093/eurheartj/ehac237.
9
The six-minute walk test in sarcoidosis associated pulmonary hypertension: Results from an international registry.结节病相关性肺动脉高压的六分钟步行试验:一项国际注册研究的结果
Respir Med. 2022 May;196:106801. doi: 10.1016/j.rmed.2022.106801. Epub 2022 Mar 16.
10
Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease: A Multidisciplinary Delphi Study.间质性肺疾病患者肺动脉高压的筛查策略:一项多学科德尔菲研究
Chest. 2022 Jul;162(1):145-155. doi: 10.1016/j.chest.2022.02.012. Epub 2022 Feb 15.